Nivolumab (brand name Opdivo) is an immunotherapy drug that blocks the PD-1 protein on T-cells to help the immune system fight cancers like melanoma, NSCLC, kidney, head/neck, and liver cancer. It is administered intravenously by healthcare professionals. Common side effects include fatigue, rash, musculoskeletal pain, and diarrhea.
See It Styled On Instagram
- No access token
Reviews
There are no reviews yet.